JP2013129604A5 - - Google Patents

Download PDF

Info

Publication number
JP2013129604A5
JP2013129604A5 JP2011278023A JP2011278023A JP2013129604A5 JP 2013129604 A5 JP2013129604 A5 JP 2013129604A5 JP 2011278023 A JP2011278023 A JP 2011278023A JP 2011278023 A JP2011278023 A JP 2011278023A JP 2013129604 A5 JP2013129604 A5 JP 2013129604A5
Authority
JP
Japan
Prior art keywords
water
cellulose
methyl
soluble
film
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011278023A
Other languages
Japanese (ja)
Other versions
JP2013129604A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2011278023A priority Critical patent/JP2013129604A/en
Priority claimed from JP2011278023A external-priority patent/JP2013129604A/en
Publication of JP2013129604A publication Critical patent/JP2013129604A/en
Publication of JP2013129604A5 publication Critical patent/JP2013129604A5/ja
Pending legal-status Critical Current

Links

Claims (5)

（Ｓ）−（−）−１−（４−フルオロイソキノリン−５−イル）スルホニル−２−メチル−１，４−ホモピペラジン又はその塩、水溶性フィルム形成剤及びカルボキシビニルポリマーを含有することを特徴とするフィルム製剤。   (S)-(-)-1- (4-fluoroisoquinolin-5-yl) sulfonyl-2-methyl-1,4-homopiperazine or a salt thereof, a water-soluble film forming agent, and a carboxyvinyl polymer. Characteristic film preparation. 水溶性フィルム形成剤が水溶性セルロース誘導体である請求項１記載のフィルム製剤。   The film preparation according to claim 1, wherein the water-soluble film forming agent is a water-soluble cellulose derivative. 水溶性セルロース誘導体がメチルセルロース、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、カルボキシメチルセルロース及びそれらの塩から選ばれる１種又は２種以上である請求項２記載のフィルム製剤。   The film preparation according to claim 2, wherein the water-soluble cellulose derivative is one or more selected from methyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, carboxymethyl cellulose and salts thereof. 眼科用フィルム製剤である請求項１〜３のいずれか１項記載のフィルム製剤。   The film preparation according to any one of claims 1 to 3, which is an ophthalmic film preparation. （Ｓ）−（−）−１−（４−フルオロイソキノリン−５−イル）スルホニル−２−メチル−１，４−ホモピペラジン又はその塩及び水溶性フィルム形成剤を含有する医薬製剤に、カルボキシビニルポリマーを含有させることを特徴とする、該医薬製剤における（Ｓ）−（−）−１−（４−フルオロイソキノリン−５−イル）スルホニル−２−メチル−１，４−ホモピペラジン又はその塩の徐放化方法。 (S) - (-) - 1-to (4-fluoro-isoquinoline-5-yl) sulfonyl-2-methyl-1,4-homopiperazine or a pharmaceutical preparation containing a salt and a water-soluble film-forming agents, carboxyvinyl characterized in that the inclusion of the polymer, in said pharmaceutical formulation (S) - (-) - 1- (-5- 4- fluoro-isoquinoline-yl) sulfonyl-2-methyl-1,4-homopiperazine or a salt thereof Sustained release method.
JP2011278023A 2011-12-20 2011-12-20 Sustained release film preparation containing glaucoma treating agent Pending JP2013129604A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011278023A JP2013129604A (en) 2011-12-20 2011-12-20 Sustained release film preparation containing glaucoma treating agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011278023A JP2013129604A (en) 2011-12-20 2011-12-20 Sustained release film preparation containing glaucoma treating agent

Publications (2)

Publication Number Publication Date
JP2013129604A JP2013129604A (en) 2013-07-04
JP2013129604A5 true JP2013129604A5 (en) 2015-02-05

Family

ID=48907480

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011278023A Pending JP2013129604A (en) 2011-12-20 2011-12-20 Sustained release film preparation containing glaucoma treating agent

Country Status (1)

Country Link
JP (1) JP2013129604A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102177199B1 (en) * 2013-04-24 2020-11-10 고쿠리쓰다이가쿠호진 규슈다이가쿠 Therapeutic agent for eyeground disease
JP2015229671A (en) * 2014-06-06 2015-12-21 株式会社デ・ウエスタン・セラピテクス研究所 Retinal pigment epithelial cell protectant

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS587605B2 (en) * 1977-09-08 1983-02-10 帝人株式会社 Sustained-release preparation and its manufacturing method
JPS6471822A (en) * 1987-09-12 1989-03-16 Rohto Pharma Ophthalmic sustained release preparation
AU720326B2 (en) * 1995-12-21 2000-05-25 Alcon Laboratories, Inc. Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia
PL1905452T3 (en) * 2005-07-12 2013-11-29 Kowa Co Agent for prevention or treatment of glaucoma
JP5081413B2 (en) * 2005-07-29 2012-11-28 参天製薬株式会社 Non-invasive drug delivery system for posterior ocular tissue using solid composition
JP2013103919A (en) * 2011-11-15 2013-05-30 Kowa Co Sustained release film preparation which contains chlorpheniramine maleate

Similar Documents

Publication Publication Date Title
ES2586057T3 (en) Sustained release tablet comprising pregabalin through a two phase release control system
JP2012530141A5 (en)
JP2013010803A5 (en)
JP2017504611A5 (en)
JP2014515013A5 (en)
JP2016539953A5 (en)
JP2007153910A5 (en)
JP2012255026A5 (en)
JP2013014622A5 (en)
JP2013510216A5 (en)
JP2016027060A5 (en)
JP2014503607A5 (en)
JP2013529637A5 (en)
HRP20192213T1 (en) Pharmaceutical composition containing mirabegron
JP2015510916A5 (en)
RU2019138248A (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION, CONTAINING ENZALUTAMIDE
JP2013129604A5 (en)
WO2010046932A3 (en) Extended release pharmaceutical composition of minocycline and process thereof
TR201001417A1 (en) Cefdinir formulation with improved dissolution rate
JP2011136977A5 (en)
JP2017537883A5 (en)
JP2013536814A5 (en)
JP2013522131A5 (en)
JP2013129605A5 (en)
RU2015141792A (en) DRY PHARMACEUTICAL COMPOSITIONS INCLUDING ACTIVE AGENT NANOPARTICLES RELATED TO CARRIER PARTICLES